Browsing by Author Tiley, Campbell

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2012All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Bradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Browett, Peter; Catalano, Alberto; Collins, Marnie; Dilulio, J.; et al, various; Firkin, Frank; Grigg, Andrew P.; Hugman, Amanda; Reynolds, John; Supple, Shane; Tiley, Campbell; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineAll-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4), Blood, vol.120, 8, 2012,pp 1570-1580
2015Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studiesStevenson, William; Bisquera, Alessandra; Clinton-Mcharg, T; Hall, Alix E; Lynagh, Marita C; Sanson-Fisher, Rob W; Tiley, Campbell; Northern Clinical School: MedicineAre Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies, Experimental Hematology & Oncology, vol.4, N/A, 2015,pp 1-8
2010Enrolment of patients to clinical trials in haematological cancer in New South Wales: Current status, perceived barriers and opportunities for improvement.Bradstock, Kenneth; Kerridge, Ian; Bishop, J F; Catanzariti, Ann-Maree; Lean, Cynthia L; Murray, P; Sinclair, S; Tiley, Campbell; Welberry, H; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Ctr for Values Ethics & Law in MedEnrolment of patients to clinical trials in haematological cancer in New South Wales: Current status, perceived barriers and opportunities for improvement., Internal Medicine Journal, vol.40, 2,pp 133-138
2016High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantationEarl, John; Gurney, Howard; Joshua, Douglas; Kerridge, Ian; McLachlan, Andrew; Shaw, Peter; Trotman, Judith; Kwan, Yiu Lam; Nath, Christa; Nivison-Smith, Ian; Presgrave, Peter; Tiley, Campbell; Zeng, Lihua; Childrens Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Ctr for Values Ethics & Law in Med; Pharmacy; Childrens Hospital Westmead: Paediatrics & Child Health; Concord Clinical School: MedicineHigh melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation, British Journal of Clinical Pharmacology, vol.82, 1, 2016,pp 149-159
2010Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapyGurney, Howard; Joshua, Douglas; Kerridge, Ian; McLachlan, Andrew; Shaw, Peter; Trotman, Judith; Duffull, Stephen B.; Earl, John W; Hegarty, Gareth; Kwan, Yiu Lam; Nath, Christa E.; Presgrave, Peter; Tiley, Campbell; Zeng, Lihua; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Ctr for Values Ethics & Law in Med; Pharmacy; Children's Hospital Westmead: Paediatrics & Child Health; Concord Clinical School: MedicinePopulation pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy, British Journal of Clinical Pharmacology, vol.69, 5,pp 484-497